Memorial Sloan Kettering Cancer Center’s Department of Medicine shared a post on X:
“Love to see a collaborator reunion!
Yelena Janjigian, Eric Van Cutsem, and Kohei Shitara caught up at GI26. Dr. Janjigian presented about a trial in progress of first-line trastuzumab deruxtecan with volrustomig and fluropyrimidine in patients with HER2-low gastric cancer, gastroesophageal junction adenocarcinoma, or esophageal adenocarcinoma.”
More posts featuring MSK Department of Medicine.